文献速递冠心病

过敏性血管痉挛性心绞痛的系统综述

Allergic vasospastic angina: a systematic review.
PubMed 文献 · Heart · 2026-08-25

该系统综述纳入1992至2022年393例过敏性血管痉挛性心绞痛(Kounis综合征)病例报告,中位年龄53岁、64%为男性,46%有一个以上心血管危险因素、32%有特应性病史。多数患者接触过敏原后表现为急性冠脉综合征,71%为ST段抬高型心肌梗死,55%的诱因药物为处方药。诊断重要,因管理与传统血管痉挛性心绞痛不同,可考虑避触过敏原及过敏反应调节治疗。

要点

  • 过敏性血管痉挛性心绞痛常以急性冠脉综合征起病,71%为ST段抬高型心肌梗死。
  • 常见诱因为处方药物(55%),32%患者有特应性病史。
  • 管理不同于传统血管痉挛性心绞痛,可考虑避触过敏原及过敏反应调节治疗。

核心结论

  • 过敏性血管痉挛性心绞痛是重要且被低估的血管痉挛性心绞痛亚型,常表现为急性冠脉综合征。
  • 诊断该病重要,因其管理与传统血管痉挛性心绞痛不同,具有避触过敏原和使用过敏反应调节治疗的潜力。

研究设计与样本

  • 遵循PRISMA指南对1992至2022年报告的过敏性血管痉挛性心绞痛病例进行系统综述。
  • 共分析393例过敏性血管痉挛性心绞痛病例报告,评估患者特征、表现症状及心脏和过敏相关检查。

主要发现

  • 393例病例报告显示中位年龄53岁,64%为男性。
  • 46%有一个以上心血管危险因素,32%有特应性病史。
  • 多数患者接触多种诱因过敏原后表现为急性冠脉综合征,其中ST段抬高型心肌梗死占71%。
  • 55%的诱因过敏原为处方药物。
  • 潜在过敏机制包括IgE介导的肥大细胞脱颗粒、嗜酸性粒细胞介导的过敏反应及其他非IgE介导的肥大细胞激活途径。

临床怎么用

  • 对表现为急性冠脉综合征的患者,应考虑过敏性血管痉挛性心绞痛(Kounis综合征)这一亚型。
  • 管理上可考虑避触过敏原及使用过敏反应调节治疗,区别于传统血管痉挛性心绞痛。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Allergic vasospastic angina (also referred to as Kounis syndrome) is an under-recognised subtype of vasospastic angina in which coronary artery spasm is precipitated by an allergen. This study evaluates the clinical characteristics, mechanisms and management of this intriguing angina subtype. METHODS: A systematic review of reported cases of allergic vasospastic angina from 1992 to 2022 was performed using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Each case report was then analysed for patient characteristics, presenting signs/symptoms and both cardiac and allergic investigations. RESULTS: A systematic review of 393 allergic vasospastic angina case reports revealed a median age of 53 years (64% males), 46% had one or more cardiovascular risk factors with 32% having an atopic history. Most patients presented with an acute coronary syndrome (ST-elevation myocardial infarct in 71%) following exposure to a wide array of precipitating allergens (55% prescription medications), with multiple potential allergic mechanisms including immunoglobulin-E (IgE)-mediated mast cell degranulation, eosinophil-mediated allergic response and other non-IgE mediated mast cell activation pathways. CONCLUSION: Allergic vasospastic angina is an important and under-recognised vasospastic angina subtype, often presenting as an acute coronary syndrome. Diagnosis of this disorder is important since management differs to conventional vasospastic angina with the potential of allergen avoidance and use of allergic response modulating therapies.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Quetsch M, Kette F, Tavella R, et al. Allergic vasospastic angina: a systematic review. Heart. 2026. PMID: 41198181. doi:10.1136/heartjnl-2025-326599

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。